Raw cornstarch and glucose readings in adults with glycogen storage disease type I

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study conducted at the University Hospital Federico II in Naples, Italy. It will monitor postprandial glucose responses in adults with glycogen storage disease type I who regularly use continuous glucose monitoring and raw cornstarch. Researchers will collect clinical and metabolic data, including anthropometrics, body composition, energy expenditure, muscle strength, and standard blood tests, to explore how cornstarch timing and dose relate to glucose profiles. The study does not assign interventions but observes real-world management as part of routine care. Findings may help refine meal timing and cornstarch use to improve glycemic control.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* confirmed genetic diagnosis of GSD Ia or Ib;
* age \>18 years;
* routine CGM use;
* habitual raw cornstarch consumption.

Exclusion Criteria:

* psychiatric disorders;
* pregnancy, celiac disease;
* dialysis treatment;
* nocturnal enteral feeding;
* severe acute or chronic illnesses.

Where it's running

• AOU Policlinico "Federico II"
  Naples, Napoli, Italy Recruiting

Study contacts

• Study coordinator: Roberta Lupoli Associated Professor, Medical Director at the AOU Federico II
• Email: roberta.lupoli@unina.it
• Phone: +39 0817462302

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home lactate and Accu‑Chek glucose meter accuracy for people with glycogen storage disease

  This project will see if a handheld Lactate Plus meter and an Accu‑Chek glucometer give results that match lab blood tests in people with glycogen storage disease types Ia, Ib, and XI.

  Recruiting Connecticut Children's Medical Center · Hartford, Connecticut · NCT07459582

• Dietary strategies for managing Glycogen Storage Disease Type I

  This study tests if allowing adults with Glycogen Storage Disease Type I to eat more foods with fructose and galactose can improve their quality of life without causing health problems.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern and 1 other locations · NCT06852612

• Glycogen Storage Disease and Brain Function in People Like You

  This study tests whether people with glycogen storage disease perform differently on cognitive tests and show different brain imaging features compared with healthy peers.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07908212

• Using advanced heart MRI to improve diagnosis and risk prediction for rare cardiomyopathies

  This project tests whether advanced cardiac MRI techniques can help diagnose and predict future risk for people with rare heart muscle diseases like Danon, Fabry, cardiac amyloidosis, Noonan syndrome, and cardiac sarcoidosis.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07336394

• Identifying patients with cardiomyopathy for potential heart transplantation

  This study is trying to find new ways to identify and understand cardiomyopathy in patients to better predict if they might need a heart transplant in the future.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Emilia-Romagna/Bologna and 2 other locations · NCT06813443

• Natural history study of rare glycogen storage diseases

  This study is collecting health information from people with rare glycogen storage diseases to better understand their conditions and help improve future treatments.

  Recruiting Duke University · Durham, North Carolina · NCT06795152

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.